Patrick Trucchio

Stock Analyst at HC Wainwright & Co.

(4.17)
# 506
Out of 5,033 analysts
387
Total ratings
44.07%
Success rate
17.7%
Average return

Stocks Rated by Patrick Trucchio

Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $30.75
Upside: +62.60%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.92
Upside: +206.12%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500$570
Current: $485.26
Upside: +17.46%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45$40
Current: $6.60
Upside: +506.06%
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10$15
Current: $6.43
Upside: +133.46%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $11.30
Upside: -11.50%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.90
Upside: +163.85%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.66
Upside: +1,414.00%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.95
Upside: +979.14%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.52
Upside: +198.33%
Reiterates: Buy
Price Target: $70
Current: $61.88
Upside: +13.12%
Reiterates: Buy
Price Target: $5
Current: $1.13
Upside: +344.44%
Reiterates: Buy
Price Target: $60
Current: $7.11
Upside: +743.88%
Reiterates: Buy
Price Target: $80
Current: $37.94
Upside: +110.86%
Reiterates: Buy
Price Target: $40
Current: $13.93
Upside: +187.15%
Reiterates: Buy
Price Target: $30
Current: $4.96
Upside: +504.84%
Reiterates: Buy
Price Target: $70
Current: $25.87
Upside: +170.58%
Reiterates: Buy
Price Target: $80
Current: $29.08
Upside: +175.10%
Maintains: Buy
Price Target: $25$10
Current: $1.97
Upside: +408.91%
Reiterates: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
Reiterates: Buy
Price Target: $55
Current: $13.10
Upside: +319.85%
Reiterates: Buy
Price Target: $110
Current: $6.12
Upside: +1,697.39%
Reiterates: Buy
Price Target: $85
Current: $62.34
Upside: +36.36%
Maintains: Buy
Price Target: $190$150
Current: $6.29
Upside: +2,284.74%
Maintains: Buy
Price Target: $170$68
Current: $15.88
Upside: +328.21%
Maintains: Outperform
Price Target: $260$340
Current: $185.13
Upside: +83.65%